GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » SBI Holdings Inc (TSE:8473) » Definitions » Research & Development

SBI Holdings (TSE:8473) Research & Development : 円0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is SBI Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. SBI Holdings's Research & Development for the three months ended in Mar. 2024 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil.

SBI Holdings Research & Development Historical Data

The historical data trend for SBI Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SBI Holdings Research & Development Chart

SBI Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SBI Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SBI Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SBI Holdings  (TSE:8473) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SBI Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of SBI Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

SBI Holdings (TSE:8473) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » SBI Holdings Inc (TSE:8473) » Definitions » Research & Development
Comparable Companies
TSE:7148 TSE:8508 TSE:8789 TSE:7338 BOM:532978 ELEKTRA SZSE:000617 TPE:2885 VOYA BOM:540691 SZSE:000987 OSL:STB SZSE:002797 SHSE:600390 SZSE:002670 BOM:500302 OHEL:MANTA SHSE:600621 ASX:AMP BKK:TCAP
Traded in Other Exchanges
SBHGF:USA ZOF:Germany ZOF:Germany
Address
1-6-1, Roppongi, Minato-ku, Tokyo, JPN, 106-6019
Website
http://www.sbigroup.co.jp
SBI Holdings Inc is a financial conglomerate that offers a variety of services in securities, banking, and insurance. Operations are divided into financial services, asset management, and biotechnology-related business. Many of the traditional financial offerings fall under the financial services arm and include housing loans and foreign exchange margin trading in addition to the primary banking and insurance businesses. Under the asset management business, the group invests in Japanese and international venture companies that operate in IT, biotechnology, environment/energy, and finance. Aside from financial services, cosmetics, health foods, and drugs are developed by subsidiaries in the biotech-related business.

SBI Holdings (TSE:8473) Headlines

No Headlines